Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
This study is creating a registry and biobank to collect and analyze information and samples from people who have received radiation therapy for solid tumors or blood cancers (hematologic malignancies) at Mayo Clinic Rochester. The goal is to understand how radiation therapy affects patients over time, including side effects (toxicities), quality of life, and how well the treatment controls the cancer. You can join if you received photon or proton radiation therapy at Mayo Clinic Rochester with the goal of curing your cancer. The study will measure how well patients do by looking at side effects and quality of life for many years.
- Study design
- This is an observational study, meaning researchers will collect information without giving new treatments. It plans to include up to 15,000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for the duration of their life, an expected average of 20 years, to analyze side effects and quality of life.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
At a glance
Conditions
NCT02457962
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Mayo Clinic
Rochester, Minnesotastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Nadia N. Laack, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- analyze acute and late toxicities using CTCAE 4.03Patients will be followed for the duration of their life, an expected average of 20 years
- analyze quality of life using LASA-3 and FACT-EPatients will be followed for the duration of their life, an expected average of 20 years